We detected a significant correlation between MAP4K4 transcript abundance and the severity of the components of NAS (liver steatosis, inflammation, hepatocellular ballooning) as well as composite NAS (Fig. 1A–D). This evidence concerns the gene MAP4K4 and fatty liver disease.